Femoral acetabular impingement clinical trials
13 active trials name this condition. Describe your situation to see which ones look like a fit.
By location
- Blood Flow Restriction Following Hip Arthroscopy
- Absorbable vs Non-Absorbable Sutures for Hip Capsular Closure
- Knotless Implants As an Alternative for Capsular Closure in Primary Hip Arthroscopy: a Prospective, Multi-Center Study
- Hip Arthroscopy Postoperative Opioid Demands
- Effect of PRP, PPP, & BMAC on Functional Outcomes Following Hip Arthroscopy for Acetabular Labral Pathologies
- An Evaluation of Hip Preservation Outcomes
- Use of BMAC With Hip Arthroscopy Treatment of FAI and Labral Tear
- Efficacy of Ketorolac for Postoperative Pain Management in Hip Arthroscopy: A Prospective Double-Blinded Randomized Controlled Trial
- Early Feasibility Study of Cartilage Defect Repair
- Psychosocial Interventions for Young Adults With Hip Pain
- Modifications of Devices for Hip Arthroscopy
- Biomechanical Assessment of Femoroacetabular Impingement
- Conjoint Analysis of Patient Preferences in Joint Interventions
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Femoral acetabular impingement” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.